Topical and Transdermal Community

Yes. Please see details below.

This will be a rare occasion to interact with the experts who developed the revisions to USP Chapter <1724>. These revisions primarily pertain to the IVRT and IVPT studies that are essential for demonstrating bioequivalence of Topical products. In fact the FDA recently issued product specific guidance for more than 80 products and most of them refer to Chapter <1724>. Now you have an opportunity to clarify your questions on these revisions. Check out the link, https://lnkd.in/efYjE34x for the revisions and feel free to send your questions in advance to [email protected].

Date & Time
2nd December 2022: In Vitro Release Test (IVRT) and Apparatus
9th December 2022: In Vitro Permeation Test (IVPT)
Time: 12PM - 1PM EST

Where:
AAPS TTC's Meeting Room
Zoom Meeting ID: 2022 12 02 09
Invite Link: https://lnkd.in/epkyHdFD

------------------------------
Lakshmi Raghavan Ph.D.
Founder & President
Solaris Pharma Corporation
Bridgewater NJ
[email protected]

Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------

Original Message:
Sent: 12-08-2022 10:06
From: Keith Hamman
Subject: Is there a meeting (Zoom) this Friday

Greetings,

 

I see on LinkedIn that there's an AAPS Topicals & Transdermal Community virtual round table panel discussion, but I don't see that event on the Topicals & Transdermal Community AASP website.

 

If there is indeed a meeting, can I have an invitation link to add to my calendar.

 

Thank you and warm regards,

 

Keith

 

 

Keith Hamman

Vice President & General Manager

Teledyne Pharma | Teledyne Hanson |Teledyne CETAC

 

Director of Sales & Business Development

Teledyne Advanced Chemistry Systems

 

Direct: +1.818.739.1820

Main:   +1.818.882.7266

 

 

 

www.teledynepharma.com

www.teledynehanson.com

www.teledyneisco.com

www.teledyneacs.com

Teledyne Confidential; Commercially Sensitive Business Data